Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Biomedical Scandinavia AB
AB
Active
Org 5591909477
Fridensborgsvägen 148, 170 62
Solna
Manufacture of other chemical products n.e.c.
·
NACE 2059
Est. 2019 · 7 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of other chemical products n.e.c.
/
Biomedical Scandinavia AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
12
84
224
379
422
Staff expenses
−0
−10
−25
−138
—
EBITDA
−95
−210
0
−10
8
Depreciation & amort.
—
—
—
—
−0
EBIT
−95
−210
0
−10
8
Net financials
0
0
−0
—
7
Profit before tax
−95
−210
−0
−10
2
Tax
—
—
−0
—
−1
Net profit
−95
−210
−0
−10
1
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
489
575
590
264
445
Equity
52
−159
51
51
51
Long-term debt
438
724
519
206
112
Short-term debt
0
10
20
7
282
Total debt
438
734
539
213
394
Financial ratios
5-year trend
EBITDA margin
−795,2 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
10,5 %
This company
38,2 %
Market median
This company
Market median
73% below market
2021
2025
Return on equity
−184,8 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2021
2025
Net profit margin
−794,7 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,02×
This company
1,12×
Market median
This company
Market median
98% below market
2021
2025
Debt / equity
8,49×
This company
0,62×
Market median
This company
Market median
>999% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Biomedical Scandinavia AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
